| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.5M | +340.9% |
| R&D Expense | $40.8M | +5.8% |
| SG&A Expense | $16.7M | +3.2% |
| Operating Income | -$52.1M | +2.0% |
| Interest Expense | $130K | +19.3% |
| Net Income | -$50.7M | +4.3% |
| EPS (Basic) | -$1.11 | +25.5% |
| EPS (Diluted) | -$1.11 | +25.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.5M | -6.0% |
| Accounts Receivable | $1.7M | +2865.8% |
| Current Assets | $51.5M | -33.3% |
| Total Assets | $61.5M | -32.6% |
| Current Liabilities | $17.1M | +47.9% |
| Long-term Debt | $4.0M | -50.0% |
| Total Liabilities | $24.4M | -4.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.0M | +4.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $25.0M | +201.6% |
| Financing Cash Flow | $11.9M | -77.9% |
| Free Cash Flow | -$40.0M | +4.8% |
| Stockholders' Equity |
| $37.1M |
| -43.5% |